Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel deuterated phenylpropionic acid derivative, preparation method thereof, and use of derivative as medicine

A deuterium propionic acid, pharmaceutical technology, applied in the field of preparation of drugs for the treatment of diabetes and metabolic syndrome, can solve the problems of unstable structure of phenylpropionic acid, no hypoglycemic activity, etc.

Active Publication Date: 2017-09-15
CHINA PHARM UNIV
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Compound 1 (structure shown below) reported by Takeda has good hypoglycemic activity, but its phenylpropionic acid structure is unstable, and it is prone to β-oxidative metabolism in vivo to generate phenylacrylic acid, which in turn generates benzoic acid. sugar activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel deuterated phenylpropionic acid derivative, preparation method thereof, and use of derivative as medicine
  • Novel deuterated phenylpropionic acid derivative, preparation method thereof, and use of derivative as medicine
  • Novel deuterated phenylpropionic acid derivative, preparation method thereof, and use of derivative as medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] 3-(4-Hydroxyphenyl)-2,2-dideuteriopropionic acid

[0105]

[0106] Step 1: Dissolve p-hydroxybenzaldehyde (1g, 8.26mmol) in 30ml of water, add cyclo(ethylene)isopropyl malonate (1.2g, 8.32mmol), and heat at 75°C for two hours to obtain a yellow turbid liquid. Suction filtration obtained 2.3 g of a yellow solid, the yield of the crude product was 113%, and the crude product was dried overnight under an infrared lamp.

[0107] The second step: take the above crude product (1g, 4.04mmol) and dissolve it in 30ml (tetrahydrofuran / methanol, 1:1, v / v) mixed solvent, slowly add NaBH under ice bath 4 (0.45g, 6.06mmol), react at room temperature for 1 hour, after TLC detects that the reaction is complete, add 50ml of water to dilute, extract with ethyl acetate (40ml×4), combine the organic phases and wash with saturated NaCl solution (20ml×2), the obtained organic The phase was dried over anhydrous sodium sulfate, filtered with suction, and the filtrate was evaporated to remo...

Embodiment 2

[0110] 2′-Methyl-[1,1′-biphenyl]-4-carbaldehyde

[0111]

[0112] The raw material 2-bromotoluene (0.5g, 2.6mmol) was dissolved in 42ml mixed solvent (toluene / ethanol / water, 3:1:3, v / v / v), and the raw material 3-formylphenylboronic acid (0.3g, 2.6mmol), triphenylphosphopalladium (0.15g, 0.13mmol), anhydrous sodium carbonate (0.69g, 6.5mmol), and heated at 60°C for 24h under nitrogen protection. After the reaction, cool to room temperature, dilute with 20ml of water, use diatomaceous earth as a pad for suction filtration, wash the filter cake with ethyl acetate (15ml×3), extract the filtrate with ethyl acetate (30ml×4), combine the organic phases with saturated NaCl solution (20ml×2), the obtained organic phase was dried over anhydrous sodium sulfate, suction filtered, the filtrate was evaporated to remove the solvent under reduced pressure, and the residue was subjected to column chromatography (petroleum ether / ethyl acetate, 70:30, v / v) Purification afforded 0.35 g of off...

Embodiment 3

[0114] 3-(4-((2′-methyl-[1,1′-biphenyl]-3-yl)methoxy)phenyl)-2,2-dideuteriopropanoic acid (I-1)

[0115]

[0116] The first step: raw material II-1 (0.2g, 1.18mmol) was dissolved in 20ml of mixed solvent (tetrahydrofuran / methanol, 1:1, v / v) solution, slowly added sodium borohydride (0.1g, 2.4mmol), after the reaction under ice bath, add 20ml water to quench the reaction, extract with ethyl acetate (30ml×3) and combine the organic phases with saturated NaCl solution (20ml×2) for washing, and the organic phases are dried with anhydrous sodium sulfate , suction filtration, and the filtrate was evaporated to remove the solvent under reduced pressure, and was directly used in the next reaction without purification.

[0117] Step 2: Dissolve the compound obtained in the previous step in 20ml of dichloromethane, slowly drop into 0.5ml of thionyl chloride, add 1 drop of DMF, and heat the reaction at 25°C. After the reaction, evaporate the solvent under reduced pressure to obtain a ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a novel deuterated phenylpropionic acid derivative represented by general formula (I), a preparation method thereof, and a use of a medicinal composition containing the derivative as a medicine for treating diabetes and metabolic syndrome. The deuterated phenylpropionic acid derivative has excellent in vivo blood sugar lowering activity, and can be used for preparing medicines for preventing or treating diabetes.

Description

technical field [0001] The present invention relates to the field of pharmacology related to diabetes, in particular to a novel deuterated phenylpropionic acid derivative, its preparation method and the application of a pharmaceutical composition containing the derivative in the preparation of medicines for treating diabetes and metabolic syndrome. The structure of the deuterated phenylpropionic acid derivatives involved in the present invention is unique and novel in the structural transformation of this type of compound, and the deuterated technology is skillfully used to block the metabolic sites of existing drugs, thereby improving pharmacokinetics academic nature. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by persistent high blood sugar, and is divided into type 1 diabetes (insulin-dependent diabetes) and type 2 diabetes (non-insulin-dependent diabetes). At present, about 415 million people in the world suffer from diabetes, an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C69/732C07C69/734C07D277/24C07D261/08C07C251/48C07C317/18A61K31/192A61K31/426A61K31/42A61P3/00A61P3/10
CPCC07B2200/05C07C69/732C07C69/734C07C251/48C07C317/18C07D261/08C07D277/24
Inventor 黄文龙钱海刘春霞李政杨建勇毕昕洲蔡星光
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com